Join
Live feed
·
INSIDERFilingvia Quantisnow
4D Molecular Therapeutics Inc. logo

VP, Finance and Controller Gupta Ashoo converted options into 1,086 shares and sold $3,377 worth of shares (389 units at $8.68), increasing direct ownership by 2% to 46,359 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FDMT (4D Molecular Therapeutics Inc.) and more on Quantisnow.